APA (7th ed.) Citation

Terpos, E., Repousis, P., Lalayanni, C., Hatjiharissi, E., Assimakopoulou, T., Vassilopoulos, G., . . . Dadakaridou, M. (2021). Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World "POWERFUL" Study. Journal of Clinical Medicine, 10(7), 1509. https://doi.org/10.3390/jcm10071509

Chicago Style (17th ed.) Citation

Terpos, Evangelos, et al. "Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World "POWERFUL" Study." Journal of Clinical Medicine 10, no. 7 (2021): 1509. https://doi.org/10.3390/jcm10071509.

MLA (9th ed.) Citation

Terpos, Evangelos, et al. "Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World "POWERFUL" Study." Journal of Clinical Medicine, vol. 10, no. 7, 2021, p. 1509, https://doi.org/10.3390/jcm10071509.